- Home
- MWG vs KZIA Comparison
MWG vs KZIA Comparison
Compare MWG & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MWG
- KZIA
- Stock Information
- Founded
- MWG 1988
- KZIA 1994
- Country
- MWG Singapore
- KZIA Australia
- Employees
- MWG N/A
- KZIA N/A
- Industry
- MWG Miscellaneous manufacturing industries
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- MWG Consumer Discretionary
- KZIA Health Care
- Exchange
- MWG Nasdaq
- KZIA Nasdaq
- Market Cap
- MWG 8.3M
- KZIA 9.0M
- IPO Year
- MWG 2023
- KZIA 1999
- Fundamental
- Price
- MWG $0.33
- KZIA $7.95
- Analyst Decision
- MWG
- KZIA Strong Buy
- Analyst Count
- MWG 0
- KZIA 2
- Target Price
- MWG N/A
- KZIA $14.00
- AVG Volume (30 Days)
- MWG 1.0M
- KZIA 19.0K
- Earning Date
- MWG 05-27-2025
- KZIA 06-05-2025
- Dividend Yield
- MWG N/A
- KZIA N/A
- EPS Growth
- MWG N/A
- KZIA N/A
- EPS
- MWG N/A
- KZIA N/A
- Revenue
- MWG $31,066,000.00
- KZIA $1,549,158.00
- Revenue This Year
- MWG N/A
- KZIA N/A
- Revenue Next Year
- MWG N/A
- KZIA $49.25
- P/E Ratio
- MWG N/A
- KZIA N/A
- Revenue Growth
- MWG N/A
- KZIA 248983.08
- 52 Week Low
- MWG $0.21
- KZIA $2.86
- 52 Week High
- MWG $0.62
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- MWG 72.41
- KZIA 49.06
- Support Level
- MWG $0.25
- KZIA $7.69
- Resistance Level
- MWG $0.39
- KZIA $8.39
- Average True Range (ATR)
- MWG 0.04
- KZIA 0.65
- MACD
- MWG 0.01
- KZIA 0.05
- Stochastic Oscillator
- MWG 67.83
- KZIA 64.55
About MWG Multi Ways Holdings Limited
Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.